Institute For Neurodegenerativ entered the industry of Medical Research in 2006 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 8139100, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact John Seibyl, President by calling (203) 401-4300 during business hours. You can also write to the business’ Single Location at 60 Temple St # 8a, New Haven, Connecticut CT 06510. You can also visit the company’s website at indd.org. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Institute For Neurodegenerativ |
Representative: | John Seibyl, President |
Place of Business: | 60 Temple St # 8a, New Haven, CT 06510 |
Contact Number: | (203) 401-4300 |
Website: | indd.org |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 8139100 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2006 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Institute For Neurodegenerativ is a company operating from New Haven, Connecticut providing professional Medical Research and relevant B2B variables. It was founded in 2006 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 8139100 as Medical Research.
With a current employee count of 1 to 4, Institute For Neurodegenerativ has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative John Seibyl, President at (203) 401-4300 for related queries, or to locate its Single Location using the coordinates 41.30487,-72.92827.
The Single Location can also be found at the street address 60 Temple St # 8a in New Haven, Connecticut 06510 and can be engaged online through the company website at indd.org, the company Twitter , and Facebook page .